Kidney-sparing surgery for upper tract urothelial cancer
Current opinion in urology, 2015•journals.lww.com
KSS should be regarded as a valid alternative to RNU in case of technically resectable low-
risk upper tract urothelial cell carcinoma, even in case of a normal contralateral kidney.
Advances in technology and biological and clinical risk estimation will make the
management of UTUC more evidence based thereby lowering overtreatment.
risk upper tract urothelial cell carcinoma, even in case of a normal contralateral kidney.
Advances in technology and biological and clinical risk estimation will make the
management of UTUC more evidence based thereby lowering overtreatment.
Summary
KSS should be regarded as a valid alternative to RNU in case of technically resectable low-risk upper tract urothelial cell carcinoma, even in case of a normal contralateral kidney. Advances in technology and biological and clinical risk estimation will make the management of UTUC more evidence based thereby lowering overtreatment.
Lippincott Williams & Wilkins以上显示的是最相近的搜索结果。 查看全部搜索结果